Histologic parameters | CHF (n=13) | Mimics (n=6) | P-value | |
---|---|---|---|---|
Biliary changes | Bile ductular-like proliferation | 13 | 3 | <0.05 |
Dilated duct at the center | 12 | 3 | N.S. | |
Linear lining of ectatic bile ducts along the limiting plate | 12 | 1 | <0.01 | |
Bile ducts crossing limiting plates | 9 | 1 | N.S. | |
Bile duct fusion and anastomosing | 11 | 2 | <0.05 | |
VMC/VMC-like structures | 6 | 0 | N.S. | |
Cholangitis (lymphocytic or neutrophilic) | 10 | 2 | N.S. | |
Bile duct loss (% loss) | 0 | 1 (68% loss) | N.S. | |
Vascular changes | Portal vein obliteration/hypoplasia | 13 | 6 | N.S. |
Portal vein dilation/herniation | 0 | 6 | <0.001 | |
Arterial hyperplasia | 13 | 6 | N.S. | |
Nodular regenerative hyperplasia | 1 | 4 | <0.05 | |
Cholestasis | Bile plugs in bile ducts and ductules | 6 | 0 | N.S. |
Bile plugs in canaliculi (lobular cholestasis) | 1 | 0 | N.S. | |
Hepatocytic cholestasis | 1 | 0 | N.S. | |
Bile infarcts | 0 | 0 | N.S. | |
Cholate stasis | 0 | 0 | N.S. | |
Inflammation | Portal inflammation | 7 | 1 | N.S. |
Interface hepatitis | 0 | 0 | N.S. | |
Lymphoid aggregates | 2 | 0 | N.S. | |
Fibrosis | Portal tract expansion with fibrosis | 13 | 1 | <0.05 |
Fibrosis stage: Ludwig (0-4) | Stage 1 (portal fibrosis) | 1 | 1 | N.S. |
Stage 2 (periportal fibrosis) | 3 | 3 | ||
Stage 3 (bridging fibrosis) | 6 | 1 | ||
Stage 4 (cirrhosis) | 3 | 1 |